Synopsys, Inc. SNPS
Verdict: Strong sell. Fair value $300 against a price of $509 on 6 Jan 2026, 41% below the price.
In plain words
The case for: Wide competitive moat provides durability. Market leadership enables pricing power. Industry tailwinds with growing market.
The case against: Intense competitive pressure could compress margins. In FY2024, Net Income surged by 84% to $2.26B while Operating Cash Flow simultaneously declined by.... The dramatic increase in Net Income in 2024 is not supported by a commensurate increase in cash....
Main risks
- Extremely poor capital allocation efficiency, with a proxied 3-year ROIIC of just 1.6%, suggesting that a massive increase in invested capital has failed to generate adequate incremental returns.
- High leverage with a Debt/Proxy EBITDA ratio of 9.4x, creating significant financial risk, especially given the recent drop in profitability and cash flow.
- Deteriorating profitability and cash flow: Net Income dropped 41% from 2024 to 2025, and Free Cash Flow remains below its 2022 peak, indicating margin pressure or integration issues.
- In FY2024, Net Income surged by 84% to $2.26B while Operating Cash Flow simultaneously declined by...
- The dramatic increase in Net Income in 2024 is not supported by a commensurate increase in cash...
- Intense competitive environment